A polymorphism of the interferon-gamma-inducible protein 30 gene is associated with hyperglycemia in severely obese individuals

Human Genetics

Volumn 131, Issue 1, 2012, Pages 57-66

  Turcot, V ^a,b   Bouchard, L ^c   Faucher, G ^a,b   Tchernof, A ^b   Deshaies, Y ^d   Perusse L ^a,e   Marceau, P ^d   Hould, F S ^d   Lebel, S ^d   Vohl, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c CHICOUTIMI HOSPITAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHEMOKINE; GLYCINE; INTERFERON GAMMA INDUCIBLE PROTEIN 30; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENOTYPE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERGLYCEMIA; LINKAGE DISEQUILIBRIUM; MALE; OBESITY; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 84856659398     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-011-1043-4     Document Type: Article

References (32)

1. IA Adzhubei S Schmidt L Peshkin VE Ramensky A Gerasimova P Bork AS Kondrashov SR Sunyaev 2010 A method and server for predicting damaging missense mutations Nat Methods 7 248 249 20354512 10.1038/nmeth0410-248 1:CAS:528:DC%2BC3cXjvFKqu78%3D
2. KG Alberti P Zimmet J Shaw 2006 Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 469 480 16681555 10.1111/j.1464-5491.2006.01858.x 1:STN:280:DC%2BD283lslGgsQ%3D%3D
3. AH Anis W Zhang N Bansback DP Guh Z Amarsi CL Birmingham 2010 Obesity and overweight in Canada: an updated cost-of-illness study Obes Rev 11 31 40 19413707 10.1111/j.1467-789X.2009.00579.x 1:STN:280:DC%2BC3cnpsFSqtw%3D%3D
4. B Arunachalam UT Phan HJ Geuze P Cresswell 2000 Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT) Proc Natl Acad Sci USA 97 745 750 10639150 10.1073/pnas.97.2.745 1:CAS:528:DC%2BD3cXot1agtw%3D%3D (Pubitemid 30070380)
5. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
6. M Bluher 2010 The distinction of metabolically 'healthy' from 'unhealthy' obese individuals Curr Opin Lipidol 21 38 43 19915462 10.1097/MOL. 0b013e3283346ccc
7. L Bouchard A Tchernof Y Deshaies S Marceau O Lescelleur S Biron MC Vohl 2007 ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics Obes Surg 17 372 382 17546847 10.1007/s11695-007-9067-5 (Pubitemid 46659299)
8. L Bouchard G Faucher A Tchernof Y Deshaies S Lebel FS Hould P Marceau MC Vohl 2009 Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals Acta Diabetol 46 13 21 18682883 10.1007/s00592-008-0049-4 1:CAS:528:DC%2BD1MXht1Orsro%3D
9. Bouchard L, Faucher G, Tchernof A, Deshaies Y, Marceau S, Lescelleur O, Biron S, Bouchard C, Perusse L, Vohl MC (2009b) Association of OSBPL11 gene polymorphisms with cardiovascular disease risk factors in obesity. Obesity (Silver Spring) 17(7):1466-1472. doi: 10.1038/oby.2009.71
10. AJ Cameron DW Dunstan N Owen PZ Zimmet EL Barr AM Tonkin DJ Magliano SG Murray TA Welborn JE Shaw 2009 Health and mortality consequences of abdominal obesity: evidence from the AusDiab study Med J Aust 191 202 208 19705980
11. DS Collins ER Unanue CV Harding 1991 Reduction of disulfide bonds within lysosomes is a key step in antigen processing J Immunol 147 4054 4059 1721638 1:STN:280:DyaK38%2FptFOjtw%3D%3D
12. Expert Panel on Detection EaToHBCiA 2001 Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2486 2497 10.1001/jama.285.19.2486
13. GR Hajer TW van Haeften FL Visseren 2008 Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur Heart J 29 2959 2971 18775919 10.1093/eurheartj/ehn387 1:CAS:528:DC%2BD1MXht1enu7s%3D
14. Hastings KT, Cresswell P (2011) Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase. Antioxid Redox Signal. doi: 10.1089/ars.2010.3684
15. AD Karelis DH St Pierre F Conus R Rabasa-Lhoret ET Poehlman 2004 Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89 2569 2575 15181025 10.1210/jc.2004-0165 1:CAS:528:DC%2BD2cXmtlGqt7Y%3D (Pubitemid 38766333)
16. IR Konig A Ziegler 2003 Group sequential study designs in genetic-epidemiological case-control studies Hum Hered 56 63 72 14614240 10.1159/000073734 (Pubitemid 37465072)
17. P Lahiry RL Pollex RA Hegele 2008 Uncloaking the genetic determinants of metabolic syndrome J Nutrigenet Nutrigenomics 1 118 125 19776621 10.1159/000112459 1:CAS:528:DC%2BD1cXlt1antrs%3D (Pubitemid 351301323)
18. E Lindholm O Melander P Almgren G Berglund CD Agardh L Groop M Orho-Melander 2006 Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality PLoS One 1 e64 17183695 10.1371/journal.pone.0000064
19. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D (Pubitemid 34164012)
20. P Marceau FS Hould S Simard S Lebel RA Bourque M Potvin S Biron 1998 Biliopancreatic diversion with duodenal switch World J Surg 22 947 954 9717420 10.1007/s002689900498 1:STN:280:DyaK1czotlWnug%3D%3D (Pubitemid 28374612)
21. M Maric B Arunachalam UT Phan C Dong WS Garrett KS Cannon C Alfonso L Karlsson RA Flavell P Cresswell 2001 Defective antigen processing in GILT-free mice Science 294 1361 1365 11701933 10.1126/science.1065500 1:CAS:528: DC%2BD3MXotlKls74%3D (Pubitemid 33063106)
22. A Martinez M Sanchez-Lopez J Varade A Mas MC Martin V de Las Heras R Arroyo JL Mendoza M Diaz-Rubio B Fernandez-Gutierrez EG de la Concha E Urcelay 2007 Role of the MHC2TA gene in autoimmune diseases Ann Rheum Dis 66 325 329 17012290 10.1136/ard.2006.059428 1:CAS:528:DC%2BD2sXjvFShtr4%3D (Pubitemid 46579632)
23. P Mathieu P Poirier P Pibarot I Lemieux JP Despres 2009 Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease Hypertension 53 577 584 19237685 10.1161/HYPERTENSIONAHA.108.110320 1:CAS:528:DC%2BD1MXivVemtr4%3D
24. P Mathieu I Lemieux JP Despres 2010 Obesity, inflammation, and cardiovascular risk Clin Pharmacol Ther 87 407 416 20200516 10.1038/clpt.2009. 311 1:STN:280:DC%2BC3c7pvVSgtg%3D%3D
25. R Singh P Cresswell 2010 Defective cross-presentation of viral antigens in GILT-free mice Science 328 1394 1398 20538950 10.1126/science.1189176 1:CAS:528:DC%2BC3cXntVyhtbg%3D
26. JL Sobell LL Heston SS Sommer 1993 Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene Am J Med Genet 48 28 35 8357034 10.1002/ajmg.1320480108 1:STN:280:DyaK3szmt1OhtA%3D%3D (Pubitemid 23119954)
27. M Teran-Garcia C Bouchard 2007 Genetics of the metabolic syndrome Appl Physiol Nutr Metab 32 89 114 17332787 10.1139/h06-102 1:CAS:528: DC%2BD2sXktFequr8%3D
28. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 Suppl 1 S5 S20
29. MC Vohl R Sladek J Robitaille S Gurd P Marceau D Richard TJ Hudson A Tchernof 2004 A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men Obes Res 12 1217 1222 15340102 10.1038/oby.2004.153 1:CAS:528:DC%2BD2cXot1Gms7g%3D (Pubitemid 41137463)
30. MC Vohl A Houde S Lebel FS Hould P Marceau 2005 Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome Mol Genet Metab 86 300 306 16122961 10.1016/j.ymgme.2005.07.002 1:CAS:528:DC%2BD2MXhtVOksb7N (Pubitemid 41412188)
31. WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i-xii, 1-253
32. DA Winer S Winer L Shen PP Wadia J Yantha G Paltser H Tsui P Wu MG Davidson MN Alonso HX Leong A Glassford M Caimol JA Kenkel TF Tedder T McLaughlin DB Miklos HM Dosch EG Engleman 2011 B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies Nat Med 17 610 617 21499269 10.1038/nm.2353 1:CAS:528: DC%2BC3MXkslCmtrg%3D